Send mail to Author

Randomized trial of the efficacy and safety of Berotralstat (BCX7353) as an oral prophylactic therapy for hereditary angioedema: results of APeX-2 ihrough 48 weeks (Part 2) (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _     ______    _  _      ___     ______     ______  
| |  | ||  /_   _//  | \| ||   / _ \\  |      \\  /_   _// 
| |/\| ||   -| ||-   |  ' ||  | / \ || |  --  //   -| ||-  
|  /\  ||   _| ||_   | .  ||  | \_/ || |  --  \\   _| ||_  
|_// \_||  /_____//  |_|\_||   \___//  |______//  /_____// 
`-`   `-`  `-----`   `-` -`    `---`   `------`   `-----`  
                                                           
 


Back to frontdoor view